TMPO and breast carcinoma: Zerumbone, a sesquiterpene compound containing two conjugated and one isolated double bonds and α, β-unsaturated carbonyl group in the 11-membered ring structure (Figure 7), exerted potent anticancer activities in breast cancer cells upon co-administration with TP5-iRGD peptide.